Immatics N.V. (IMTX)
IMTX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.83
-5.27% on the day
Market cap
$1.0B
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | IMTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Germany |
| IPO year | Not reported by the screener |
| SEC CIK | 0001809196 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | P7 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2026-08-25 |
| Latest annual report | 20-F | 2026-03-05 |
| Latest quarterly / interim | 6-K | 2026-08-26 |
Source: SEC EDGAR submissions feed, 241 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.8% |
| 1 month | -20.1% |
| 3 months | -26.9% |
| Year to date | -34.6% |
| 1 year | -31.9% |
| From 52-week high | -42.1% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MGTX | MeiraGTx Holdings plc | $9.94 | -4.24% | $954.7M |
| VOR | Vor Biopharma Inc. | $19.06 | -3.74% | $1.1B |
| REPL | Replimune Group Inc. | $12.11 | -7.34% | $1.1B |
| CGEM | Cullinan Therapeutics Inc. | $14.10 | -5.69% | $907.4M |
| TSHA | Taysha Gene Therapies Inc. | $3.58 | -13.53% | $1.2B |
| SLBT | SL Science Holding Limited | $1.53 | +1.32% | $858.0M |
| GLUE | Monte Rosa Therapeutics Inc. | $9.89 | -5.99% | $843.7M |
| ODTX | Odyssey Therapeutics Inc. | $17.24 | -5.59% | $828.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier